Argos Therapeutics Reports Results of Interim Analysis of the ADAPT Trial and Announces Review of Strategic Alternatives

    NEXT STORY
    Matinas BioPharma to Present Positive Preclinical Data of MAT2203 at the 28th European Congress of Clinical Microbiology and Infectious Disease
    PREV STORY
    XORTX Announces PKD Foundation Collaboration
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Tobias Linebäck appointed to lead GHP International

    GHP Specialty Care AB (publ) (GHP) has appointed the company’s CFO and Deputy CEO ...

    author_avatar
    NASDAQ Market News

    GENFIT Signs an Agreement for the Enhancement of Medical Knowledge & Landscape of NASH Research

    GENFIT Signs an Agreement for the Enhancement of Medical Knowledge & Landscape of NASH ...

    author_avatar
    NASDAQ Market News

    Aduro Biotech Reports Third Quarter 2017 Financial Results

    BERKELEY, Calif., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today reported ...

    author_avatar
    NASDAQ Market News